Warnock, David G.

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 890

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Kurella Tamura, M., Wadley, V., Yaffe, K., McClure, L. A., Howard, G., Go, R., Allman, R. M., Warnock, D. G., & McClellan, W. (2008) · American Journal of Kidney Diseases

Dementia and Cognitive Impairment ResearchChronic Kidney Disease and Diabetes

Cited by 388

Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Baber, U., Howard, V. J., Halperin, J. L., Soliman, E. Z., Zhang, X., McClellan, W., Warnock, D. G., & Muntner, P. (2011) · Circulation Arrhythmia and Electrophysiology

Atrial Fibrillation Management and OutcomesChronic Kidney Disease and Diabetes

Cited by 247

Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD

Tanner, R. M., Calhoun, D. A., Bell, E. K., Bowling, C. B., Gutiérrez, O. M., Irvin, M. R., Lackland, D. T., Oparil, S., Warnock, D., & Muntner, P. (2013) · Clinical Journal of the American Society of Nephrology

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 168

Current and Investigational Therapeutics for Fabry Disease

Felis, A., Whitlow, M., Kraus, A., Warnock, D. G., & Wallace, E. (2020) · Kidney International Reports

Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus

Cited by 100